The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Dafna D. Gladman

Centre for Prognosis Studies in the Rheumatic Diseases

Toronto Western Hospital

Room 1E-410B

399 Bathurst Street

Canada

[email]@utoronto.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Room 1E-410B, 399 Bathurst Street, Canada. 1998 - 2012
  • Toronto Western Hospital, 399 Bathurst Street, 1E410B, Toronto. 2009 - 2012
  • University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada. 2003 - 2010
  • University of Toronto, Toronto, Canada. 2001 - 2010
  • Toronto Western Research Institute, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, University Health Network, Canada. 2009

References

  1. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Touma, Z., Urowitz, M.B., Taghavi-Zadeh, S., Ibañez, D., Gladman, D.D. Rheumatology. (Oxford) (2012) [Pubmed]
  2. The Path Forward to Biomarker Discovery in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting. Gladman, D.D., Ritchlin, C.T., Fitzgerald, O. J. Rheumatol. (2012) [Pubmed]
  3. Patient-reported Outcome in Psoriatic Arthritis: A Comparison of Web-based Versus Paper-completed Questionnaires. Mackenzie, H., Thavaneswaran, A., Chandran, V., Gladman, D.D. J. Rheumatol. (2011) [Pubmed]
  4. Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a Canadian Clinical Practice Setting: The REPArE Trial. Gladman, D.D., Bombardier, C., Thorne, C., Haraoui, B., Khraishi, M., Rahman, P., Bensen, W., Syrotuik, J., Poulin-Costello, M. J. Rheumatol. (2011) [Pubmed]
  5. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Eder, L., Chandran, V., Pellett, F., Pollock, R., Shanmugarajah, S., Rosen, C.F., Rahman, P., Gladman, D.D. Ann. Rheum. Dis. (2011) [Pubmed]
  6. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. Touma, Z., Urowitz, M.B., Fortin, P.R., Landolt, C., Toloza, S.M., Riddell, C., Chandran, V., Eder, L., Ghanem, A., Ziouzina, O., Taghavi-Zadeh, S., Ibañez, D., Gladman, D.D. J. Rheumatol. (2011) [Pubmed]
  7. Informing response criteria for psoriatic arthritis. I: discrimination models based on data from 3 anti-tumor necrosis factor randomized studies. Gladman, D.D., Tom, B.D., Mease, P.J., Farewell, V.T. J. Rheumatol. (2010) [Pubmed]
  8. Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study. Gladman, D.D., Sampalis, J.S., Illouz, O., Guérette, B. J. Rheumatol. (2010) [Pubmed]
  9. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. Gladman, D.D., Tandon, A., Ibañez, D., Urowitz, M.B. J. Rheumatol. (2010) [Pubmed]
  10. Informing response criteria for psoriatic arthritis (PsA). II: Further considerations and a proposal--the PsA joint activity index. Gladman, D.D., Tom, B.D., Mease, P.J., Farewell, V.T. J. Rheumatol. (2010) [Pubmed]
  11. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2008. Gladman, D.D. J. Rheumatol. (2010) [Pubmed]
  12. Composite measures in psoriatic arthritis: GRAPPA 2008. Gladman, D.D., Landewé, R., McHugh, N.J., Fitzgerald, O., Thaci, D., Coates, L., Mease, P.J., Qureshi, A.A., Krueger, G.G., Ritchlin, C.T., Kavanaugh, A.F., Garg, A. J. Rheumatol. (2010) [Pubmed]
  13. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Gladman, D.D., Schentag, C.T., Tom, B.D., Chandran, V., Brockbank, J., Rosen, C., Farewell, V.T. Ann. Rheum. Dis. (2009) [Pubmed]
  14. Spondyloarthropathies: Targeted therapy for psoriatic arthritis. Gladman, D.D. Nat. Rev. Rheumatol (2009) [Pubmed]
  15. Cardiovascular morbidity in psoriatic arthritis. Gladman, D.D., Ang, M., Su, L., Tom, B.D., Schentag, C.T., Farewell, V.T. Ann. Rheum. Dis. (2009) [Pubmed]
  16. Psoriatic arthritis. Gladman, D.D. Dermatol. Ther (2009) [Pubmed]
  17. GRAPPA at the European League Against Rheumatism (EULAR) 2008. Gladman, D.D., Helliwell, P.S., Mease, P.J. J. Rheumatol. (2009) [Pubmed]
  18. Psoriatic arthritis from Wright's era until today. Gladman, D.D. J. Rheumatol. Suppl (2009) [Pubmed]
  19. GRAPPA 2007: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. Gladman, D.D. J. Rheumatol. (2008) [Pubmed]
  20. Clinical and genetic registries in psoriatic disease. Gladman, D.D., Rahman, P., Krueger, G.G., Mease, P.J., Qureshi, A.A., Dutz, J.P., Lindqvist, U., Carneiro, S., Helliwell, P.S., Ujfalussy, I., Gottlieb, A.B., Behrens, F., Ståhle, M. J. Rheumatol. (2008) [Pubmed]
  21. Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis. Gladman, D.D. Nature Clinical Practice. Rheumatology (2008) [Pubmed]
  22. Can we identify psoriatic arthritis early?. Gladman, D.D. Curr. Rheumatol. Rep (2008) [Pubmed]
  23. Mortality in psoriatic arthritis. Gladman, D.D. Clin. Exp. Rheumatol. (2008) [Pubmed]
  24. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Gladman, D.D., Mease, P.J., Cifaldi, M.A., Perdok, R.J., Sasso, E., Medich, J. Ann. Rheum. Dis. (2007) [Pubmed]
  25. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. Gladman, D.D., Inman, R.D., Cook, R.J., Maksymowych, W.P., Braun, J., Davis, J.C., Landewé, R.B., Mease, P., Brandt, J., Vargas, R.B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F.D., Khan, M.A., Pipitone, N., Rahman, P., Reveille, J.D., Stone, M.A., Taylor, W., Veale, D.J., van der Heijde, D. J. Rheumatol. (2007) [Pubmed]
  26. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Gladman, D.D., Mease, P.J., Ritchlin, C.T., Choy, E.H., Sharp, J.T., Ory, P.A., Perdok, R.J., Sasso, E.H. Arthritis Rheum. (2007) [Pubmed]
  27. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. Gladman, D.D., Inman, R.D., Cook, R.J., van der Heijde, D., Landewé, R.B., Braun, J., Davis, J.C., Mease, P., Brandt, J., Vargas, R.B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F.D., Khan, M.A., Pipitone, N., Rahman, P., Reveille, J.D., Stone, M.A., Taylor, W., Veale, D.J., Maksymowych, W.P. J. Rheumatol. (2007) [Pubmed]
  28. Outcome measures in psoriatic arthritis. Gladman, D.D., Mease, P.J., Healy, P., Helliwell, P.S., Fitzgerald, O., Cauli, A., Lubrano, E., Krueger, G.G., van der Heijde, D., Veale, D.J., Kavanaugh, A., Nash, P., Ritchlin, C., Taylor, W., Strand, V. J. Rheumatol. (2007) [Pubmed]
  29. Axial disease in psoriatic arthritis. Gladman, D.D. Curr. Rheumatol. Rep (2007) [Pubmed]
  30. A novel, disease-specific quality-of-life instrument for patients with SLE. Gladman, D.D. Nature Clinical Practice. Rheumatology (2006) [Pubmed]
  31. Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?. Gladman, D.D. Ann. Rheum. Dis. (2006) [Pubmed]
  32. Longitudinal cohort studies. Gladman, D.D., Farewell, V.T. J. Rheumatol. Suppl (2005) [Pubmed]
  33. Introduction/overview on clinical registries. Gladman, D.D., Menter, A. Ann. Rheum. Dis. (2005) [Pubmed]
  34. Psoriatic arthritis clinical registries and genomics. Gladman, D.D., Ritchlin, C., Helliwell, P.S. Ann. Rheum. Dis. (2005) [Pubmed]
  35. Consensus exercise on domains in psoriatic arthritis. Gladman, D.D. Ann. Rheum. Dis. (2005) [Pubmed]
  36. OMERACT 7 psoriatic arthritis workshop: synopsis. Gladman, D.D., Strand, V., Mease, P.J., Antoni, C., Nash, P., Kavanaugh, A. Ann. Rheum. Dis. (2005) [Pubmed]
  37. Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review. Gladman, D.D. Drugs (2005) [Pubmed]
  38. HLA markers for susceptibility and expression in scleroderma. Gladman, D.D., Kung, T.N., Siannis, F., Pellett, F., Farewell, V.T., Lee, P. J. Rheumatol. (2005) [Pubmed]
  39. Outcome measures in psoriatic arthritis. Gladman, D.D., Mease, P.J., Krueger, G., van der Heidje, D.M., Antoni, C., Helliwell, P.S., Kavanaugh, A.F., Nash, P., Ritchlin, C.T., Strand, C.V., Taylor, W. J. Rheumatol. (2005) [Pubmed]
  40. The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. Gladman, D.D., Cook, R.J., Schentag, C., Feletar, M., Inman, R.I., Hitchon, C., Karsh, J., Klinkhoff, A.V., Maksymowych, W.P., Mosher, D.P., Nair, B., Stone, M.A. J. Rheumatol. (2004) [Pubmed]
  41. Psoriatic arthritis. Gladman, D.D. Dermatol. Ther (2004) [Pubmed]
  42. Effectiveness of psoriatic arthritis therapies. Gladman, D.D. Semin. Arthritis Rheum. (2003) [Pubmed]
  43. Established criteria for disease controlling drugs in ankylosing spondylitis. Gladman, D.D. Ann. Rheum. Dis. (2003) [Pubmed]
  44. HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs. Gladman, D.D., Farewell, V.T., Pellett, F., Schentag, C., Rahman, P. Hum. Immunol. (2003) [Pubmed]
  45. The nature and outcome of infection in systemic lupus erythematosus. Gladman, D.D., Hussain, F., Ibañez, D., Urowitz, M.B. Lupus (2002) [Pubmed]
  46. Current concepts in psoriatic arthritis. Gladman, D.D. Curr. Opin. Rheumatol (2002) [Pubmed]
  47. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. Gladman, D.D., Chaudhry-Ahluwalia, V., Ibañez, D., Bogoch, E., Urowitz, M.B. J. Rheumatol. (2001) [Pubmed]
  48. HLA-DRB1*04 alleles in psoriatic arthritis: comparison with rheumatoid arthritis and healthy controls. Gladman, D.D., Farewell, V.T., Rahman, P., Schentag, C.T., Pellett, F., Ng, C.M., Wade, J.A. Hum. Immunol. (2001) [Pubmed]
  49. Accurately describing changes in disease activity in Systemic Lupus Erythematosus. Gladman, D.D., Urowitz, M.B., Kagal, A., Hallett, D. J. Rheumatol. (2000) [Pubmed]
  50. Psoriatic arthritis. Gladman, D.D., Brockbank, J. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  51. Clinical aspects of the spondyloarthropathies. Gladman, D.D. Am. J. Med. Sci. (1998) [Pubmed]
 
WikiGenes - Universities